The Guid has described the AMA's position as “misleading,” “predictable” and an example of “professional protectionism,” arguing that specially trained, condition‑based pharmacist prescribers will safely reduce dangerous delays in care.
Latest Video
New Stories
-
The minister is following a tried and tested process, but what is the risk in this new world?
July 1, 2026 - - Latest News -
Patient alarm over the potential loss of subsidised access to MS medicines
July 1, 2026 - - Latest News -
Significant day marked by negotiation trigger and wholesaler remuneration changes
July 1, 2026 - - Latest News -
Protection gap leaves older Australians vulnerable this winter
July 1, 2026 - - Latest News -
Pharmacy Guild rejects AMA alarm over broader prescribing powers
July 1, 2026 - - Latest News -
Governments backs inhaled RNA therapy with the potential to change the future of chronic lung disease treatment
July 1, 2026 - -
Major new survey shows patients paying more and waiting longer for medicines
July 1, 2026 - - Latest News


